ArticleClinical ophthalmology (Auckland, N.Z.)2013

Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions.

Michael A Singer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.